by Graham Fitzgibbon | May 6, 2021 | Briefings
Biden’s Decision to Ease Patent Rules on Vaccines for Poorer Countries We begin with the Biden Administration’s decision to support easing patent rules which has Big Pharma alarmed and is already getting pushback from countries like Germany. Joining...
by Graham Fitzgibbon | May 5, 2021 | Briefings
Facebook’s Non-Decision on Making its Ban of Trump Permanent We begin with the decision or non-decision by Facebook to maintain its ban against Donald Trump on its platform which was enacted on January 7, the day after the attack on the Capitol that Trump...
by Graham Fitzgibbon | May 4, 2021 | Briefings
Trump’s GOP Demands Loyalty to the “Big Lie” While Purging Truth-Tellers We begin with a Republican Party now in the hands of a wannabe-dictator who lost the last election but launched the “stop the steal” campaign to both make...
by Graham Fitzgibbon | May 3, 2021 | Briefings
With 30% Resisting Vaccination, the U.S. is Unlikely to Reach Herd Immunity We begin with the scientific consensus emerging that the U.S. is unlikely to reach herd immunity as the vaccination rate declines with more than half of adults who wanted to be...
by Graham Fitzgibbon | May 2, 2021 | Briefings
Giuliani in Trouble and Putin Under Threat From Hardliners At Home We begin with growing legal pressure on Rudy Giuliani as federal investigators scrutinize his electronic devices and assess whether he might turn on Trump who cut him loose after refusing to pay...
